Effector Therapeutics

Effector Therapeutics

Effector Therapeutics

Effector Therapeutics is an early-stage company focused on the discovery anddevelopment of small molecule cancer therapeutics.
Founded
2012
Raised
$83.6M
Follow us
Alexa global traffic share
Latest funding
Team Size
10+
Employees
$38,600,000 Venture capital (Series C)
Xconomy , vcaonline

Effector Raises $38.6M to Advance New Class of Anti-Cancer Drugs

Funding Health Science
$40,000,000 Venture capital (Series B)
The San Diego Union-Tribune

Effector Therapeutics raises $40 million

Science Health Funding